This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Insurers Q3 Earnings to Watch on Oct 24: AFL, TMK, UNM, MKL (Revised)
by Zacks Equity Research
Insurers earnings for the third quarter should gain from higher premiums and investment income, and a lower tax rate, partly offset by catastrophe losses.
Insurers Q3 Earnings to Watch on Oct 24: AFL, TMK, UNM, MKL
by Zacks Equity Research
Insurers earnings for the third quarter should gain from higher premiums and investment income, and a lower tax rate, partly offset by catastrophe losses.
Markel (MKL) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Markel (MKL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progressive (PGR) Q3 Earnings Top Estimates on Solid Revenues
by Zacks Equity Research
Progressive's (PGR) Q3 shows an improved top line, partially offset by escalated expenses.
Chubb (CB) Provides Q3 Catastrophe Loss Estimate of $372M
by Zacks Equity Research
Chubb's (CB) preliminary net loss estimates for the third quarter of 2018 might mar the prospects of its impending results, inducing volatility to underwriting income.
Brown & Brown Rewards Shareholders With 6.7% Dividend Hike
by Zacks Equity Research
Brown & Brown (BRO) instills investors' confidence in the stock with a dividend increase of 6.7%.
Here's Why You Should Add Progressive (PGR) to Your Portfolio
by Zacks Equity Research
Progressive Corporation (PGR) promises exciting returns for investors on the back of five factors.
Everest Re Gains From Wide Product Portfolio, Cat Loss a Woe
by Zacks Equity Research
Everest Re (RE) continues to impress with wide product portfolio, top-line growth and robust capital position. However, exposure to cat loss remain a dampener.
CNA Financial Gains From Premium Growth, Costs on the Rise
by Zacks Equity Research
CNA Financial (CNA) continues to impress with premium growth, better performing Long Term Care business and robust capital position. However, rising costs remain a dampener.
Alleghany's (Y) Top-Line Growth Impresses, Cat Loss a Woe
by Zacks Equity Research
Alleghany's (Y) top-line improvement, strategic initiatives and a robust capital position continue to encourage investors. However, exposure to cat loss persists to be a spoiler.
Allstate to Offer Identity Protection With InfoArmor Buyout
by Zacks Equity Research
Allstate (ALL) acquires InfoArmor to expand its Benefits business offering.
Unum Group Expands Base in Poland With Pramerica Buyout
by Zacks Equity Research
Unum Group's (UNM) acquisition of Pramerica will help widen its footprint in Poland as well as strengthen its financial protection offering.
Markel (MKL) to Acquire Brahmin Through Markel Venture
by Zacks Equity Research
Markel (MKL) lends a nod to buy Brahmin in tandem with its strategy to invest in profitable business beyond insurance via Markel Ventures.
Brown & Brown's Unit Buyout to Improve Service Portfolio
by Zacks Equity Research
Brown & Brown (BRO) arm buys Vandroff Insurance, which is anticipated to add value to its service portfolio while providing a combination of coverage, service and price.
Arthur J. Gallagher Consolidates Portfolio With Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Rogers & Young Insurance Services will help it solidify its portfolio of coverages to better serve clients in San Francisco and Oregon.
Markel's Premium Growth Encourages, Rising Costs a Drag
by Zacks Equity Research
Markel (MKL) continues to gain from consistent premium growth, strategic buyouts and a strong capital position. However, rising expenses are a spoiler.
Markel to Brace Berth in Insurance-Linked Securities Sector
by Zacks Equity Research
Markel (MKL) envisions to be the largest manager of funds in insurance-linked securities sector with the buyout of Nephila Holdings Limited.
Markel (MKL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Markel (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markel (MKL) Hits 52-Week High: Can the Bull Run Continue?
by Zacks Equity Research
Markel (MKL) scales 52-week high in Aug 21 trading session on strong second-quarter 2018 earnings.
Markel (MKL) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Markel (MKL) Q2 reflects higher revenues and improved premiums at the Insurance segment.
7 Reasons Why You Should Add Markel (MKL) to Your Portfolio
by Zacks Equity Research
We focus on seven factors, which make Markel (MKL) an attractive pick for investors.
Progressive's (PGR) May Earnings Ride on Higher Revenues
by Zacks Equity Research
Progressive's (PGR) May earnings reflect an improved top line as well as solid policies in force.
Here's Why You Must Add AXIS Capital (AXS) to Your Portfolio
by Zacks Equity Research
AXIS Capital (AXS) looks promising to earn better returns for investors owing to six factors.
Arch Capital Stock to Split, Shares to be More Affordable
by Zacks Equity Research
Arch Capital's (ACGL) stock spilt for 3:1 to lower value of the same shares and in turn, increase the stock's liquidity.
Here's Why You Should Retain Chubb (CB) in Your Portfolio
by Zacks Equity Research
Chubb (CB) promises a better reward for investors on the back of seven factors.